StocksFin Logo
Impel Pharmaceuticals Inc. country of incorporation
|
|
Mr. Adrian Adams
|
129 employees
NASDAQ | Healthcare | Biotechnology
NeuroPace, Inc. country of incorporation
|
|
Mr. Michael Favet
|
174 employees
NASDAQ | Healthcare | Medical Devices
Q322 reported Nov 14, 2022 Reporting Period
$3.08M 3386713.2% vs. Q321 Revenues Q322
51.07% 129.2% vs. Q321 Gross Profit Margin
-1000% ! 0% vs. Q321 Net Profit Margin
-47.05M ! -173.1% vs. Q321 Free Cash Flow Q322
$-1.31 ! -50284.6% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 8, 2022 Reporting Period
$11.16M 7.9% vs. Q321 Revenues Q322
71.39% -1.7% vs. Q321 Gross Profit Margin
-105.63% ! -35.1% vs. Q321 Net Profit Margin
-7.01M ! -58.4% vs. Q321 Free Cash Flow Q322
$-0.48 ! -41.2% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
4.3
9.91
Current Ratio
4.97
11.08
Cash Ratio
3.99
0.6
Price to Book
-5.18
2.14
Price to Sales
37.46
8.31
Price to Earnings
-0.93
-1.97